name,category,termschromosome 17 open reading frame 91,SP_PIR_KEYWORDS[790000356$complete proteome]
chromosome 17 open reading frame 91,UP_SEQ_FEATURE[850055239$chain:Putative uncharacterized protein C17orf91, 850117294$sequence conflict]
ubiquitin-like modifier activating enzyme 7,INTERPRO[450000009$IPR000011:Ubiquitin-activating enzyme, E1-like, 450000108$IPR000127:Ubiquitin-activating enzyme repeat, 450000507$IPR000594:UBA/THIF-type NAD/FAD binding fold, 450014426$IPR016040:NAD(P)-binding domain, 450016375$IPR018074:Ubiquitin-activating enzyme, E1, active site, 450016376$IPR018075:Ubiquitin-activating enzyme, E1, 450017235$IPR018965:Ubiquitin-activating enzyme e1, C-terminal, 450017809$IPR019572:Ubiquitin-activating enzyme]
ubiquitin-like modifier activating enzyme 7,KEGG_PATHWAY[470038837$hsa04120:Ubiquitin mediated proteolysis, 470038892$hsa05012:Parkinson's disease]
ubiquitin-like modifier activating enzyme 7,SP_PIR_KEYWORDS[790000138$atp-binding, 790000356$complete proteome, 790000445$direct protein sequencing, 790000859$ligase, 790001063$nucleotide-binding, 790001212$polymorphism, 790001304$repeat, 790001593$ubl conjugation pathway]
ubiquitin-like modifier activating enzyme 7,UP_SEQ_FEATURE[850000085$active site:Glycyl thioester intermediate, 850068136$chain:Ubiquitin-like modifier-activating enzyme 7, 850106263$nucleotide phosphate-binding region:ATP, 850109949$region of interest:2 approximate repeats, 850115075$repeat:1-1, 850115091$repeat:1-2, 850117294$sequence conflict, 850117295$sequence variant]
